Creo Medical Group (LON:CREO) Stock Price Up 17.8% – What’s Next?

Creo Medical Group PLC (LON:CREO)’s share price was up 17.8% during trading on Wednesday . The stock traded as high as GBX 16.20 ($0.22) and last traded at GBX 16.20 ($0.22). Approximately 8,278,319 shares traded hands during trading, an increase of 510% from the average daily volume of 1,356,147 shares. The stock had previously closed at GBX 13.75 ($0.19).

Creo Medical Group Stock Performance

The stock has a market cap of £65.19 million, a price-to-earnings ratio of -2.55 and a beta of 0.86. The company has a debt-to-equity ratio of 29.96, a quick ratio of 2.19 and a current ratio of 3.24. The company’s 50 day simple moving average is GBX 10.97 and its 200 day simple moving average is GBX 14.89.

Creo Medical Group (LON:CREO) last released its earnings results on Monday, May 19th. The company reported GBX (8) (($0.11)) EPS for the quarter. Creo Medical Group had a negative net margin of 73.93% and a negative return on equity of 41.79%. On average, equities research analysts anticipate that Creo Medical Group PLC will post -10.0800005 earnings per share for the current year.

About Creo Medical Group

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.